Novel hetaryl-[1,8]naphthyridine derivatives of formula (I) wherein R1, R2, W1, W3, W5 and W6 have the meaning according to claim 1, are inhibitors of ATP consuming proteins, and can be employed, inter alia, for the treatment of tumors.
新型杂环-[1,8]
萘啶衍
生物的
化学式(I),其中R1、R2、W1、W3、W5和W6的含义如权利要求书中所述,是
ATP消耗蛋白的
抑制剂,可用于治疗肿瘤。